Product Information
CRYSELLE-28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2930 per EA under NDC 00555904958. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 30, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555904958
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075840FDA Approved
11/30/2001
TE Code
AB
On Market Since
7/24/2002
Price Statistics
The NADAC for CRYSELLE-28 TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2930 per EA |
|---|---|
| All-time high | $0.6139 (Nov 12, 2014) |
| All-time low | $0.2841 (Jul 22, 2026) |
| 52-week high | $0.3813 |
| 52-week low | $0.2841 |
| Median price | $0.4370 |
| Average price | $0.4431 |
| Largest weekly change | +27.0% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CRYSELLE-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CRYSELLE-28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2930 per EA (NDC 00555904958), effective Aug 19, 2026.
How has the price of CRYSELLE-28 TABLET changed over time?
Over the history we have for it, the NADAC for CRYSELLE-28 TABLET has declined 51.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CRYSELLE-28 TABLET?
Since Nov 28, 2013, the NADAC for CRYSELLE-28 TABLET has ranged from a low of $0.2841 (Jul 22, 2026) to a high of $0.6139 (Nov 12, 2014), with a median of $0.4370 per EA.
Are there cheaper alternatives to CRYSELLE-28 TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CRYSELLE-28 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CRYSELLE-28 TABLET?
CRYSELLE-28 TABLET (NDC 00555904958) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.